Allison’s Chemist is now able to privately vaccinate certain patients against both Meningitis B (MenB) and Human Papilloma Virus (HPV).  We are delighted to be able to complement the NHS offering with the intention to provide valuable options for the protection of our patients.

Meningitis B

Vaccines are the only way to prevent meningitis and have almost eliminated some other causes of this deadly disease.  Since the first meningitis vaccine was introduced against Hib meningitis in 1992, many kinds of meningitis have been reduced or have dwindled to a mere handful of cases, including Hib, MenC and pneumococcal.

Thanks to meningitis vaccines, thousands of children are alive today who would otherwise have died or been left seriously disabled from these deadly diseases.  The addition of the MenB vaccine will save even more.

Babies born on or after 1 July 2015 are being vaccinated with MenB alongside other routine immunisations at 2, 4 and 12 months of age.

Babies born between 1 May and 30 June 2015 should also be offered the vaccine alongside their routine immunisations as part of a one off catch up:

  • Those who have not yet received any routine immunisations should be offered MenB at the same time as their first and third routine infant vaccinations
  • Those who have already received their first dose of routine vaccinations should have MenB at the same time as their second and third routine vaccinations
  • Those who have already received their first and second dose of routine vaccinations should have MenB at the same time as their third routine vaccinations
  • A booster dose of MenB should be offered at 12 to 13 months

Babies and children born before 1 May 2015 will not be offered any doses of the vaccine on the NHS.

For those children aged over 2 years who were not eligible for the NHS service, please get in touch to see if they are eligible for our private service.  Two doses of vaccine are needed and cost £100 per dose (April 2017).


Meningitis B Vaccine Resources

NHS Choices

Meningitis Research Foundation


Human Papilloma Virus (HPV) Vaccine

What is HPV?

The human papilloma virus (HPV) is the name given to a family of viruses.

Different types of HPV are classed as either high risk or low risk, depending on the conditions they can cause. For instance, some types of HPV can cause warts or verrucas.

Other types are associated with cervical cancer.

In 99% of cases, cervical cancer occurs as a result of a history of infection with high-risk types of HPV. Often, infection with the HPV causes no symptoms.

All girls aged 12 to 13 are offered HPV (human papilloma virus) vaccination as part of the NHS childhood vaccination programme.

The vaccine protects against cervical cancer. It’s usually given to girls in year eight at schools in England.

According to Cancer Research UK, cervical cancer is the second most common cancer in women under the age of 35. In the UK, 2,900 women a year are diagnosed with cervical cancer, that’s around eight women every day.

Around 970 women died from cervical cancer in 2011 in the UK. It’s estimated that about 400 lives could be saved every year in the UK as a result of vaccinating girls before they are infected with HPV.

The HPV vaccine is delivered largely through secondary schools, and consists of two injections into the upper arm spaced at least six, and not more than 24 months apart (girls who began vaccination before September 2014 receive three injections).

Boys and HPV

The HPV vaccine should help protect boys against genital warts. Gardasil (which is the vaccine we use as well as Gardasil 9) protects against two strains of HPV that are responsible for 90% of genital warts.

Genital warts are not usually serious but they can be difficult to treat and cause distress.

Some experts have argued that routine vaccination in boys should reduce the number of oral cancer cases.

There has been a sharp rise in oral cancer cases in recent years – from 4,400 a year in 2002 to 6,200 in 2012, according to Cancer Research UK, with two thirds of cases occurring in men.

It is thought that the rise in cases may be associated with high-risk strains of HPV that can be spread during oral sex (in both heterosexual couples and in men who have sex in men).

Boys are routinely vaccinated against HPV in many other developed nations such as Australia and the US. It’s clear that officials in the UK would want to understand whether such a programme would be safe, effective and provide value for taxpayers’ money.


Our private vaccination service allows us to vaccinate both males and females from the age of 9 years.  Those aged less than 15 years will need two doses and those aged 15 years or over will require three doses, as the immune response isn’t as good in that age group.  As of April 2017 we charge £140 per dose.


HPV Resources

NHS Choices

Jo’s Trust